Trending Now
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Announces Its Focus And Progress Across Its...
When a team of distinguished scientific leaders came together in 2002, they did not know that their vision would forever transform people's lives. Their...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Esperion Therapeutics Inc (NASDAQ: ESPR) Announced Its Support for a New...
Esperion Therapeutics Inc (NASDAQ: ESPR) recently supported a study investigating the impact of bempedoic acid and Ezetimibe on the temporary reduction of the LDL...
MAKE IT MODERN
LATEST REVIEWS
Ocugen Inc (NASDAQ: OCGN) Enters The Canadian Market With Covaxin: Explores...
Ocugen Inc (NASDAQ: OCGN) in alliance with Bharat Biotech develops Covid vaccine – Covaxin, which can act against new coronavarius variants.
MAKE IT MODERN
PERFORMANCE TRAINING
Nabriva’s (NASDAQ:NBRV) XELENTA Shows Efficacy In Treating Community-Acquired Bacterial Pneumonia Patients Above 65 Years
Nabriva Therapeutics plc (NASDAQ:NBRV) has announced that XELENTA (lefamulin ) has shown significant efficacy in a posthoc analysis of LEAP 1and LEAP Phase 3...
Crypto Acceptance Continues to Build on Wall Street (MSTR, RIOT, ISWH, MARA)
The demand for cryptocurrency exposure continues to ramp. The latest example of this trend comes from Goldman Sachs. In a Reuters piece...
Axsome Therapeutics Inc. (NASDAQ:AXSM) Announces Development Status For AXS-05 In The Treatment Of Alzheimer’s...
There are hundreds of people facing unsatisfactory treatments for CNS disorders. Due to the limitation of treatment options, Axsome Therapeutics Inc (NASDAQ:AXSM) has taken...
Ardelyx Inc’s (NASDAQ: ARDX) Appeal to the Drug Advisory Committee Gets Temporarily Allowed
Ardelyx Inc (NASDAQ: ARDX) recently announced that certain health regulatory bodies such as the Centre for Disease Control and the Food and Drugs Authority...
Lipocine Inc. (NASDAQ: LPCN And Antres Pharma signs Exclusive Commercialization Agreement for TLANDO In...
Lipocine Inc. (NASDAQ: LPCN) and Antres Pharma Inc. have signed an exclusive licensing agreement for the commercialization of TLANDO in the US. TLANDO is...
MAKE IT MODERN
